Accueil/Actions/ACET

ACET

USD

Adicet Bio Inc. Common Stock

$0.620+0.012 (1.957%)

Prix en Temps Réel

Healthcare

Biotechnologie

États-Unis

Graphique des Prix

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$0.608

Haut

$0.635

Bas

$0.585

Volume

0.00M

Fondamentaux de l'Entreprise

Capitalisation Boursière

53.7M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.84M

Bourse

NGM

Devise

USD

Intervalle sur 52 Semaines

Bas $0.447Actuel $0.620Haut $1.865

Actualités Connexes

5heures · 20:30

BusinessWire

Adicet Bio Announces Oral Presentation Highlighting Preclinical ADI-270 Data at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting

Adicet Bio, Inc. (NASDAQ:ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the acceptance of an abstract

Adicet Bio Announces Oral Presentation Highlighting Preclinical ADI-270 Data at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting

17 avr. 2025 · 11:00

BusinessWire

Adicet Bio Appoints Michael Grissinger to the Board of Directors

--Mr. Grissinger brings more than four decades of leadership experience in pharmaceutical business development and strategic transactions-- Adicet Bio, Inc. (NASDAQ:ACET), a clinical stage biotechnology company